Naweed Muhammad is a pharmaceutical scientist/executive as well as a registered pharmacist in the states of California and Arizona. He spent more than 14 years in drug research and holds more than ten patents/patent applications around noteworthy innovations in pain management and drug design. Most recently, he has worked as a consultant in pharmaceutical R&D besides practicing as a pharmacist. Previously, he was a director of the pre-clinical R&D department at Vapogenix, Houston, Texas. Before that, he was a senior research scientist at Neurogesx in San Mateo, California (a start-up that became a public company) and was on the R&D team that developed Qutenza®. His experience in drug research includes opportunities to work with several global research organizations, including 3M, Harvard University, and SRI International. One of his patented inventions has completed phase-II clinical studies and is ready to move to phase-III clinical trials. Abuse-resistant opioid analgesic prodrugs (patent issued) and acetaminophen’s decades-old solubility problem were also solved by him, as well as the design of innovative prodrug molecules for a wide range of other drug moieties (patent issued). Mr. Muhammad holds a BS Pharmacy degree from Punjab University, Lahore, and an MS chemistry degree from California State University, Sacramento.